<DOC>
	<DOCNO>NCT01204255</DOCNO>
	<brief_summary>RATIONALE : Lorazepam , diphenhydramine hydrochloride , haloperidol gel , absorbed skin , may effective treatment nausea vomiting.PURPOSE : This clinical trial study lorazepam , diphenhydramine hydrochloride , haloperidol gel healthy volunteer .</brief_summary>
	<brief_title>Lorazepam , Diphenhydramine Hydrochloride , Haloperidol Gel Healthy Volunteers</brief_title>
	<detailed_description>OBJECTIVES : I . To study absorption three component topical ABH gel 10 healthy volunteer , determine adverse effect . OUTLINE : Patients apply lorazepam , diphenhydramine hydrochloride , haloperidol gel topically 2 minute . After completion study treatment , patient follow 5 hour .</detailed_description>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Lorazepam</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<criteria>Completed medical screening questionnaire English speaking No allergy drug Able complete form If woman childbearing age , agree use contraception History substance abuse , psychiatric disorder , acquire brain injury , possibility pregnancy ( use birth control , child bearing age ) Use medication would contraindicate benzodiazepine administration Pregnant nursing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>healthy , evidence disease</keyword>
</DOC>